G&L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs

Millburn, NJ, October 09, 2017 --(PR.com)-- G&L Scientific Inc., a leading provider of Clinical Research and Regulatory Affairs consulting to the healthcare industry, is delighted to announce the appointment of Richard Edmunds as Vice President, Regulatory Affairs.

Richard has successfully set up and led numerous long-term, large-scale regulatory projects and teams across the entire product lifecycle, from clinical development to new product filings and post-approval activities for pharmaceutical, biologics and consumer health products.

During his 15 years in regulatory consulting, Richard has gained a deep understanding of Regulatory Affairs in the US, EU, and international markets. Coupled with a strong focus on client needs, together with regulatory-specific project management skills, Richard is known for delivering projects to the highest standard.

“I am delighted and excited that Richard is joining G&L Scientific. Having previously worked with him for over a decade, I have no doubt that his progressive approach is perfectly suited to help drive our global regulatory affairs service,” said CEO of G&L Scientific, Stephen Loughrey.

Mr. Loughrey added, “The fact that G&L was able to attract and secure such a talented and well-respected individual speaks volumes for the reputation of our company for delivering world-class services.”

Richard will be based in G&L’s offices in Millburn, NJ.

Connect with Richard on LinkedIn: https://www.linkedin.com/in/richard-edmunds-0454b72b/